Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01436279 · ClinicalTrials.gov registry record · Phase 3
Mifepristone Versus Osmotic Dilator Insertion for Cervical Preparation Prior to Surgical Abortion at 15-18 Weeks
A Phase 3 study, sponsored by Boston University.
- Completed
- Registry status
- Phase 3
- Development phase
- 50
- Enrollment target
NCT01436279 is a Phase 3 study that has completed, run by Boston University. The registered enrollment target is 50 participants.
The verdict
NCT01436279, a Phase 3 study, has completed, sponsored by Boston University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 50 participants
- Enrollment target
Study Summary
In this study the investigators plan to compare mifepristone and misoprostol use to osmotic dilator use for cervical preparation for 15-18 week surgical abortion. Mifepristone would be given 24 hours prior to abortion, and misoprostol 400 mcg would be administered buccally 2 hours prior to abortion. Osmotic dilators are the method currently used in our institution, and are placed 24 hours prior to abortion. The primary outcome will be the length of the procedure. Secondary outcomes will include amount of dilation achieved, ease of procedure, participant's assessment of discomfort before mifepristone or dilators, discomfort during the abortion procedure, acceptability to participants, and acceptability to staff.
Interventions
- DRUG Mifepristone
- DEVICE osmotic dilators
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2011-07 |
| Est. Completion | 2013-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01436279
The ClinicalTrials.gov registry entry for NCT01436279 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Mifepristone is the first listed.
NCT01436279 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01436279 about?
NCT01436279 is a clinical study titled "Mifepristone Versus Osmotic Dilator Insertion for Cervical Preparation Prior to Surgical Abortion at 15-18 Weeks". In this study the investigators plan to compare mifepristone and misoprostol use to osmotic dilator use for cervical preparation for 15-18 week surgical abortion. Mifepristone would be given 24 hours prior to abortion, and misoprostol 400 mcg would be administered buccally 2 hours prior to abortion....
What is the current status of trial NCT01436279?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 50 participants. The study started on 2011-07. Estimated completion is 2013-08.
What interventions are being tested in trial NCT01436279?
The interventions under investigation include: Mifepristone (DRUG), osmotic dilators (DEVICE).
Who is sponsoring clinical trial NCT01436279?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.